Galectin Announces Receiving of US Patent for GR-MD-02 By: Benzinga via Benzinga May 28, 2014 at 07:39 AM EDT Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and ... Read More >> Related Stocks: Galectin Therapeutic